Senior Scientist I/II, Hematology- Target Biology and Discovery
Novartis - Cambridge (USA)
Posted Oct 28, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified checked Nov 20, 2026
- Salary
- $94K-$183K From the posting source checked Nov 17, 2026
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Market context
- U.S. role benchmark (BLS OEWS)
- $81,444 U.S. median for this role
- Projected growth (BLS Employment Projections)
- +6.9% - Faster than average
70% above the BLS role benchmark for healthcare aggregate.
Matched to SOC 29-1141 - Healthcare aggregate by role bucket.
Source:U.S. Bureau of Labor Statistics, OEWS, May 2024andEmployment Projections, 2024-2034.
Role
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered From the posting source checked Nov 17, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Senior Scientist I/II, Hematology- Target Biology and Discovery Cambridge (USA) Band Level 3 Job Description Summary #LI-OnSite Location: Cambridge This position is located in Cambridge, MA and does not have the ability to be located remotely. Please only apply if this area is accessible to you. The Oncology Department at Novartis Biomedical Research is seeking a highly motivated and collaborative laboratory scientist to join our Target Biology and Discovery group in Cambridge, Massachusetts. In this role, you will help identify and validate novel therapeutic targets and advance early drug-discovery programs for hematologic cancers, with a particular focus on myeloid malignancies. You will combine hands-on molecular and cellular biology with disease-relevant model systems to answer critical drug-discovery questions and generate insights that shape project strategy and investment decisions. Job Description R ole Description and Key Responsibilities Identify critical drug-discovery questions and independently develop creative experimental strategies. Conduct studies supporting novel target identification, target validation, and mechanism of action in hematologic malignancies such as AML/MDS, using molecular and cellular approaches such as CRISPR-based perturbation, gene knockdown/overexpression, and chemical probes. Develop and optimize cellular assays to drive early therapeutic development or perform deep mechanistic studies, applying techniques such as western blotting, qPCR, imaging, and cellular phenotyping as appropriate to the scientific question. Establish and use disease-relevant hematologic models, including primary patient-derived or healthy hematopoietic samples and tissues, cancer cell lines, and engineered cellular systems. Collaborate effectively in a matrixed, multidisciplinary environment to develop project strategy prioritize hypotheses, and adapt plans as data emerge.
Read the full description at novartis.wd3.myworkdayjobs.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Senior Scientist, Translational Preclinical Models, MPS Automated Cell Culture & Innovation
Novartis - Cambridge (USA)
Medical Monitor/Senior Medical Monitor, Hematology
Tessera Therapeutics - Somerville, Massachusetts, United States
Senior Analyst, Drug Development & Clinical Strategy
Quotient Labs - Cambridge, MA
Scientist I/II, Pre-Clinical Pharmacology
Monte Rosa Therapeutics Inc - Boston, MA, US